Th2 cytokine inhibition and cough in asthmatic and bronchitic patients

References

• Fireman P. Understanding asthma pathophysiology. Allergy Asthma Proc 2003;24:79–83.
   PubMed Web of Science ®Google Scholar
• Barns PJ. Mechanisms: Inflammation. In: Weiss EB, Stein M, eds. Bronchial asthma, Mechanisms and therapeutics. 3rd ed. Boston, Toronto, London: Little, Brown and Co.; 1993:80–94.
   Google Scholar
• Azzawi M, Bradley B, Jeffery PK, Frew A J, Wardlaw AJ, Knowles G, et al. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am Rev Respir Dis 1990;142:1407–13.
   Google Scholar
• American Thoracic Society. Standards for the diagnosis and care of the patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136: 225–44.
   PubMed Web of Science ®Google Scholar
• Miotto D, Christodoulopoulos P, Olivenstein R, Taha R, Cameron L, Tsicopoulos A, et al. Expression of IFN-gamma-inducible protein:monocyte chemotactic proteins 1,3, and 4: and eotaxin in TH1- and TH2-mediated lung diseases. J Allergy Clin Immunol 2001;107:664–70.
   PubMed Web of Science ®Google Scholar
• Fujimura M, Kamio Y, Kasahara K, Bando T, Hashimoto T, Matsuda T. Prostanoids and cough response to capsaicin in asthma and chronic bronchitis. Eur Respir J 1995;8:1499–505.
   PubMed Web of Science ®Google Scholar
• Fujimura M, Kamio Y, Hashimoto T, Matsuda T. Throm-boxane A2 and sulfidopeptide leukotrienes in cough reflex in response to inhaled capsaicin in asthmatic subjects. J Jpn Soc Bronchology 1998;20:4–10.
   Google Scholar
• Ishiura Y, Fujimura M, Yamamori C, Nobata K, Myou S, Kurashima K, et al. Thromboxane antagonism and cough in chronic bronchitis. Ann Med 2003;35:135–9.
   PubMed Web of Science ®Google Scholar
• Yanagihara Y, Kiniwa M, Ikizawa T, Shida N, Matsuura N, Koda A. Supression of IgE production by IPD-1151T (supla-tast tosilate), a new dimethylsulfonium agent: Regulation of human IgE response. Jap J Pharmacol 1993;61:23–39.
   PubMedGoogle Scholar
• Kay AB. Allergy and allergic diseases. N Engl J Med 2001044: 30–7.
   Google Scholar
• Homma H, Yamanaka A, Tanimoto S, Tamura M, Chiji-matsu Y, Kira S, et al. Diffuse panbronchiolitis: a disease of the transitional zone of the lung. Chest 1983;83:63–9.
   Google Scholar
• Suzaki H, Ichimura K, Kudoh S, Sugiyama Y, Maeda H, Symposium II. Sinobronchial syndrome and its related subjects: clinical observation in sinobronchial syndrome from a viewpoint of otorhinolaryngology. J Jap Bronchoesophagol Soc 1987;38:181–6.
   Google Scholar
• Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M. Improvement of survival in patients with diffuse panbronch-iolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 1998;157:1829–32.
   Google Scholar
• Ishiura Y, Fujimura M, Saito M, Shibata K, Nomura M, Nakatsumi Y, et al. Additive effect of continuous low-dose ofloxacin on erythromycin therapy for sinobronchial syn-drome. Respir Med 1995;89:677–84.
   PubMed Web of Science ®Google Scholar
• Fujimura M, Sakamoto S, Kamio Y, Matsuda T. Effects of methacholine-induced bronchoconstriction and procaterol-induced bronchodilation on cough receptor sensitivity to inhaled capsaicin and tartaric acid. Thorax 1992;47:441–5.
   PubMed Web of Science ®Google Scholar
• Ohrui T, Funayama T, Sekizawa K, Yamaya M, Sasaki H. Effects of inhaled beclomethasone dipropionate on serum IgE levels and clinical symptoms in atopic asthma. Clin Exp Allergy 1999;29:357–61.
   Google Scholar
• Irwin RS, Corrao WM, Pratter MR. Chronic persistent cough in the adult: the spectrum and frequency of causes and successful outcome of specific therapy. Am Rev Respir Dis 1981;123:413–7.
   Google Scholar
• Higenbottam T. Cough induced by changes of ionic composi-tion of airway surface liquid. Bull Eur Physiopathol Respir 1984;20:553–62.
   PubMedGoogle Scholar
• Bousquet J, Chanez P, Lacoste JY, Barneon G, Ghavanian N, Enander I, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033–9.
   PubMed Web of Science ®Google Scholar
• Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, et al. Predominant Th2-like bronhcoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 1992;326:298–304.
   PubMed Web of Science ®Google Scholar
• Heinzel FP, Sadick MD, Holady BJ, Coffman RL, Locksley RM. Reciprocal expression of interferon y or IL-4 during the solution or progression of murine leishmaniasis: evidence for expansion of distinct helper T cell subsets. J Exp Med 1989; 169:59–72.
   Google Scholar
• Romagnani S. Human Th1 and Th2 subsets: doubt no more. Immunol Today 1991;12:256–7.
   PubMedGoogle Scholar
• Tamaoki J, Kondo M, Sakai N, Aoshiba K, Tagaya E, Nakata J, et al. Effect of suplatast tosilate, a Th2 cytokine inhibitor, on steroid-dependent asthma: a double blind randomized study. Lancet 2000;356:273–8.
   PubMed Web of Science ®Google Scholar
• Yoshida M, Aizawa H, Inoue H, Matsumoto K, Koto H, Komori M, et al. Effect of suplatast tosilate on airway hyperresponsiveness and inflammation in asthma patients. J Asthma 2002;39:545–52.
   PubMed Web of Science ®Google Scholar
• Fujimura M, Kamio Y, Hashimoto T, Matsuda T. Airway cough sensitivity to inhaled capsaicin and bronchial respon-siveness to methacholine in asthmatic and bronchitic subjects. Respirology 1998;3:267–72.
   PubMedGoogle Scholar
• Sano Y, Miyamoto T, Makino S. Anti-inflammatory effect of suplatast tosilate on mild asthma. Chest 1997;112:862–3.
   PubMed Web of Science ®Google Scholar